Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for TB006 in Alzheimer's disease spanning Phase 1 and Phase 2, completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TB006

Snippet

Sponsor: TrueBinding, Inc. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-18